Merge, a leading provider of cardiovascular imaging solutions and ranked Best in KLAS for Cardiology and Hemodynamics, signed an agreement to partner with Us2.ai, a leader in artificial intelligence for echocardiography. Us2.ai is seamlessly integrated with Merge Cardio and aims to improve confidence in clinical outcomes and help clients deliver higher quality cardiac care with AI-powered diagnostic tools that enhance efficiency, accuracy and workflows in echocardiography.
The partnership integrates Us2.ai’s cutting-edge, FDA-cleared algorithms with Merge Cardio’s advanced imaging systems to deliver AI-generated analysis and reporting of echocardiograms. Using AI technology, Merge Cardio clients will be able to automatically detect a broad range of echocardiogram parameters, including critical measurements like disease indication, using both pattern recognition algorithms and measurement-based international guidelines. This comprehensive set of disease detection algorithms and measurements offers cardiologists a new level of automation, enabling time savings, consistency and reliability in measurements while delivering a more streamlined experience for all stakeholders.
“Using this new A.I. tool helps to streamline the screening process by identifying candidates more efficiently and by doing so, frees up critical resources needed for a successful care,” said Eugene Chung, MD, cardiologist at The Christ Hospital Health Network. “As a system that does thousands of echocardiograms a year, this new device will help lower the backlog of patients who need these heart screenings while making our entire cardiovascular team more efficient. With this system in place, we can get more face time with our patients to care for their needs in the Greater Cincinnati region.”
The Christ Hospital, a 620-bed hospital renowned for its state-of-the-art cardiology program in the Cincinnati, Ohio tri-state region, has been addressing the challenges of increasing patient volumes and echocardiogram appointment backlogs while continuously improving cardiology workflows and patient outcomes. With more than 20 years of partnership with Merge Cardio, the hospital has seen a remarkable transformation in its cardiology department.
“The Christ Hospital Health Network continues to do everything it takes to leverage the latest healthcare technologies to improve outcomes for our patients,” said Matt Strange, Vice President & Chief Risk Officer. “This new collaboration empowers our physicians with tools and technology that enable them to continue to provide patients with the highest quality and most innovative care not just in Greater Cincinnati, but across the country.”
The combined tightly integrated solution will enable cardiology teams to enhance workflows with features such as color-coded icons to instantly identify measurement origins. It will also open new opportunities for improved clinical outcomes and additional reimbursements with the ability to detect key parameters and identify heart failure with preserved ejection fraction, as well as other cardiac diseases.
“Us2.ai’s capabilities align with Merge’s mission to empower clinicians with smart and intuitive solutions,” said Ashish Sant, Executive Vice President and General Manager of Merge. “Through this partnership, we’re proud to continue paving the way for more consistent, precise, and efficient diagnostic workflows in cardiology.”
The integration is designed to be seamless, requiring no additional systems or interfaces. By simplifying complex steps and reducing time spent on manual measurements, healthcare providers can maximize daily study capacity without losing focus on patient care.
“Together with Merge, Us2.ai is focused on providing solutions clinicians can use to provide great patient care,” said Seth Koeppel, us2.ai Head of Business Development. “This partnership reflects the growing healthcare trend of incorporating innovative technologies to drive measurable improvements in patient outcomes and physician experience.“
Merge by Merative empowers healthcare organizations with advanced medical imaging solutions to enhance workflows, optimize care delivery, and improve patient outcomes. Trusted by 6 of the 10 largest U.S. health systems and built on a cloud-native foundation, Merge’s portfolio includes solutions for Vendor-Neutral Archive (VNA), PACS, Workflow Orchestration, Cardiology and Hemodynamics, and Digital Pathology. Learn more at merative.com/merge.
Us2.ai is a pioneer in the development of AI technology for cardiovascular care. The company’s mission is to leverage advanced AI algorithms to assist healthcare professionals in diagnosing and treating heart disease more accurately and efficiently. Us2.ai’s solution is FDA cleared and designed to integrate seamlessly into clinical workflows, providing valuable insights that improve patient care and outcomes. Learn more at us2.ai